Complete pathological response in patients with locally advanced cancer of breast and positive Her2/neu with neoadjuvant chemotherapy

被引：0
|
作者：
Heidy Cedeño
Rafael Araúz
Fernando Cebamanos
Idalmis de Torraza
Ana Porcell
机构：
[1] Instituto Oncológico Nacional,Department Internal Medicine
[2] Instituto Oncológico Nacional,Department of Medical Oncology
[3] Department of Radiation Oncology Instituto Oncológico Nacional,Department of Pathology
[4] Instituto Oncológico Nacional,undefined
来源：
BMC Cancer | / 7卷 / Suppl 1期
关键词：
Trastuzumab; Axillary Lymph Node; Anthracyclines; Advanced Breast Cancer; Complete Pathological Response;
D O I：
10.1186/1471-2407-7-S1-A50
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Neoadjuvant chemotherapy in locally advanced breast cancer: Clinicopathological characteristics and correlation with pathological complete response.
    Choudhary, Priyanshu
    Gogia, Ajay
    Deo, Svs
    Mathur, Sandeep
    Sharma, Dayanand
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [32] The Role of Postmastectomy Radiotherapy in Locally Advanced Breast Cancer After Pathological Complete Response to Neoadjuvant Chemotherapy
    Flores-Balcazar, Christian Haydee
    Castro-Alonso, Francisco Javier
    Hernandez-Barragan, Tania Patricia
    Delgado-de la Mora, Jesus
    Daidone, Antonino
    Trejo-Duran, Guadalupe Elizabeth
    ONCOLOGY-NEW YORK, 2021, 35 (03): : 139 - 143
  • [33] Estrogen Receptor Expression: Possible Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients
    Wu, J.
    Shen, K.
    Chen, X.
    Chen, C.
    Hu, Z.
    Liu, G.
    Di, G.
    Lu, J.
    Wu, J.
    Shao, Z.
    Shen, Z.
    CANCER RESEARCH, 2009, 69 (24) : 572S - 572S
  • [34] Neoadjuvant treatment of HER2 and hormone-receptor positive breast cancer - Moving beyond pathological complete response
    Di Cosimo, Serena
    Arpino, Grazia
    Generali, Daniele
    BREAST, 2014, 23 (02): : 188 - 192
  • [35] Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials
    Bria, Emilio
    Carbognin, Luisa
    Furlanetto, Jenny
    Pilotto, Sara
    Bonomi, Maria
    Guarneri, Valentina
    Vicentini, Cecilia
    Brunelli, Matteo
    Nortilli, Rolando
    Pellini, Francesca
    Sperduti, Isabella
    Giannarelli, Diana
    Pollini, Giovanni Paolo
    Conte, Pierfranco
    Tortora, Giampaolo
    CANCER TREATMENT REVIEWS, 2014, 40 (07) : 847 - 856
  • [36] Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer
    Katayama, Ayaka
    Miligy, Islam M.
    Shiino, Sho
    Toss, Michael S.
    Eldib, Karim
    Kurozumi, Sasagu
    Quinn, Cecily M.
    Badr, Nahla
    Murray, Ciara
    Provenzano, Elena
    Callagy, Grace
    Martyn, Cian
    Millican-Slater, Rebecca
    Purdie, Colin
    Purnell, Dave
    Pinder, Sarah E.
    Oyama, Tetsunari
    Shaaban, Abeer M.
    Ellis, Ian
    Lee, Andrew H. S.
    Rakha, Emad A.
    MODERN PATHOLOGY, 2021, 34 (07) : 1271 - 1281
  • [37] Methodology Used to Determine HER2 Status Correlates with Response to Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer
    Cheng, Esther
    McIntire, Patrick
    D'Alfonso, Timothy
    Ginter, Paula
    MODERN PATHOLOGY, 2018, 31 : 54 - 54
  • [38] Pathological complete response and prognosis after neoadjuvant chemotherapy in patients with HER2-low breast cancer
    Qiao, Weiqiang
    Guo, Wanying
    Liu, Qipeng
    Guo, Xiao
    Deng, Miao
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2023, 64
  • [39] Methodology Used to Determine HER2 Status Correlates with Response to Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer
    Cheng, Esther
    McIntire, Patrick
    D'Alfonso, Timothy
    Ginter, Paula
    LABORATORY INVESTIGATION, 2018, 98 : 54 - 54
  • [40] Clinical, radiological and pathological assessment of response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
    Srivastava, A
    Bosu, NK
    Coshic, O
    Kumar, A
    Dawar, R
    Bandhu, S
    Goyal, A
    BRITISH JOURNAL OF CANCER, 2001, 85 : 49 - 49
12345